Magnesium Sulphate
Indication: Pre-eclampsia and eclampsia for maternal seizure prophylaxis and treatment
Interactive magnesium sulphate population PK simulator for pre-eclampsia and eclampsia. Magnesium sulphate reduces seizure risk through central NMDA receptor antagonism and neuromuscular membrane stabilization. The model supports IV and IM dosing, body-weight and renal function covariates, and clinical dosing exploration for maternal seizure prophylaxis and treatment.
Drug Overview
Clinical Context
- Molecular Target
- NMDA receptor antagonism and calcium-mediated neuromuscular stabilization
- Drug Class
- Anticonvulsant / Electrolyte
- Therapeutic Area
- Obstetrics / Maternal-Fetal Medicine
- Indication
- Pre-eclampsia and eclampsia for maternal seizure prophylaxis and treatment
- Route of Administration
- IV and IM
Model Information
- Model Type
- 1-compartment PopPK with IV and IM dosing
This simulator was built from published pharmacometric literature using PKPDBuilder's AI-powered model extraction pipeline.
About This Simulator
This interactive pharmacokinetic simulator for Magnesium Sulphate allows you to explore concentration-time profiles under different dosing scenarios. The underlying 1-compartment PopPK with IV and IM dosing model characterizes the pharmacokinetics of this anticonvulsant / electrolyte following iv and im administration.
Use the simulator to visualize key exposure metrics including AUC (area under the curve), Cmax (peak concentration), and Ctrough (trough concentration).
Built with PKPDBuilder — an AI-powered platform that transforms published pharmacometric literature into interactive, deployable Shiny applications. No coding required.
Frequently Asked Questions
What is the Magnesium Sulphate PK simulator?
This is a free, interactive pharmacokinetic simulator for Magnesium Sulphate used in Pre-eclampsia and eclampsia for maternal seizure prophylaxis and treatment. It allows researchers, pharmacologists, and students to explore concentration-time profiles, dosing regimens, and exposure metrics based on published population PK models.
What drug class does Magnesium Sulphate belong to?
Magnesium Sulphate is classified as a Anticonvulsant / Electrolyte that targets NMDA receptor antagonism and calcium-mediated neuromuscular stabilization. It is used in the Obstetrics / Maternal-Fetal Medicine therapeutic area.
What route of administration does this model simulate?
This simulator models IV and IM administration of Magnesium Sulphate. The pharmacokinetic parameters (absorption rate, bioavailability, volume of distribution) are specific to this route.
What type of PK model is used?
This simulator uses a 1-compartment PopPK with IV and IM dosing model. Population PK models account for interindividual variability and covariate effects on drug exposure.
Is this simulator free to use?
Yes, all PKPDBuilder simulators are completely free. They are built from published pharmacokinetic literature and are intended for research and educational purposes. No login is required to run simulations.
Can I use this for clinical dosing decisions?
No. This simulator is for research and educational purposes only. It should not be used for clinical decision-making or patient dosing. Always consult the prescribing information and clinical pharmacology guidelines for therapeutic drug use.
Related Simulators
Magnesium Sulphate
Pre-eclampsia and eclampsia for maternal seizure prophylaxis and treatment
Magnesium Sulphate PK Simulator
Pre-eclampsia and Eclampsia (seizure prophylaxis)
NCA BET
Antenatal corticosteroid therapy for fetal lung maturation; placental transfer characterization
Ready to Simulate?
Launch the Magnesium Sulphate simulator to explore dosing scenarios and pharmacokinetic profiles interactively.
🚀 Launch SimulatorComments
⚠️ Disclaimer
This simulator is for research and educational purposes only. It is not intended for clinical decision-making, patient dosing, or therapeutic drug monitoring. Pharmacokinetic parameters are derived from published literature and represent population-level estimates. Individual patient pharmacokinetics may differ significantly. Always consult approved prescribing information and qualified healthcare professionals for clinical decisions.
Powered by PKPDBuilder.com • Free pharmacokinetic simulators for the scientific community